• News
  • Film and TV
  • Music
  • Tech
  • Features
  • Celebrity
  • Politics
  • Weird
  • Community
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
YouTube
Submit Your Content
62-year-old man’s ‘aggressive’ tumor shrinks in half in just 6 weeks after first-of-its-kind experimental treatment

Home> News> UK News

Updated 10:56 30 Oct 2024 GMTPublished 10:53 30 Oct 2024 GMT

62-year-old man’s ‘aggressive’ tumor shrinks in half in just 6 weeks after first-of-its-kind experimental treatment

Paul Read, 62, was diagnosed with glioblastoma in December 2023

Britt Jones

Britt Jones

A man in the UK who was given just a year to live has seen his brain tumor cut down in size by half after undergoing a new kind of cancer treatment.

Paul Read, 62, was diagnosed with glioblastoma in December 2023, a type of cancer which typically has a prognosis of 18 months.

However, an experimental treatment was tested on Paul, who saw a ‘50 percent’ reduction of his tumor thanks to the first-of-its-kind trial.

The treatment took place at the University College London Hospitals NHS Foundation Trust (UCLH), where doctors had surgeons remove as much of the tumor as they were able to before implanting a device called an Ommaya reservoir under his scalp.

Advert

Paul Read was diagnosed in 2023 (University College London Hospitals NHS Foundation Trust)
Paul Read was diagnosed in 2023 (University College London Hospitals NHS Foundation Trust)

After the device was fitted, the doctors went on to inject low levels of radioactivity into the tumor once a week for six weeks in total.

These injections were the key component, as doctors hoped it would kill the cancer cells but leave the surrounding tissue alone.

"Really quite remarkable"

As the treatment plan came to an end, brain scans incredibly showed that Paul’s tumor had ‘reduced in size by 50 percent’.

Advert

Dr Paul Mulholland, a consultant medical oncologist and chief investigator who leads the Glioblastoma Research Group at the UCL Cancer Institute, said: “We’ve just gone through [Paul’s] scan results with him and his end of treatment scan shows a reduction in the tumor, which is really quite remarkable for somebody whose tumor is so aggressive.”

In response to his results, Paul said in a statement: “This trial was a lifeline, as the likelihood of survival, according to the data, was a year or less for me.”

Dr Mulholland added in his statement via the hospital: “We have been working with Ariceum Therapeutics for some years to develop this study. It will allow us to deliver low levels of radioactivity directly into the tumour of patients with recurrent glioblastoma.

His tumor shrank by 50 percent (University College London Hospitals NHS Foundation Trust)
His tumor shrank by 50 percent (University College London Hospitals NHS Foundation Trust)

Advert

“I’m very pleased that this clinical trial is now open. Potentially this is a very powerful approach and I’m already extremely happy with the results from the first patient.

"I’m also very proud at how my colleagues in neurosurgery and nuclear medicine have come together as a team to deliver a really novel trial.”

"Potentially this is a very powerful approach"

Thankfully, Paul only noted being ‘a little more tired’ during his treatment and no major side effects were recorded.

Advert

The CITADEL-123 trial at UCLH was offered to Paul following his diagnosis and he ‘was happy to explore anything’.

Paul said: “We are all dealt a hand of cards and you don’t know which ones you are going to get.”

Before he underwent his treatment, he shared: “It will be wonderful if this treatment helps me and if it doesn’t, it doesn’t… it may benefit someone else down the line.”

Now, the same team who helped Paul are in the process of treating a second patient using the same procedure, with plans to expand to 40 patients in phase one of the trial.

Featured Image Credit: University College London Hospitals NHS Foundation Trust

Topics: Cancer, Health, UK News

Britt Jones
Britt Jones

Advert

Advert

Advert

Choose your content:

13 hours ago
14 hours ago
15 hours ago
  • 13 hours ago

    Scientists issue warning for surprising item people use that's 40 times dirtier than a toilet seat

    Scientists found that your travel companion is harboring a dirty secret

    News
  • 13 hours ago

    Bizarre photo of Trump as Superman shared by White House has people questioning one thing

    The image shared by the White House has left social media users confused

    News
  • 14 hours ago

    Friends and family of Idaho students killed by Bryan Kohberger explain why they thought they were 'next' in chilling new documentary

    The small Idaho community was racked with anxiety after a stranger murdered four college roommates while they slept in 2022

    News
  • 15 hours ago

    Japan breaks record for fastest internet that's 3.5 million times faster than US and can download Netflix in 1 second

    Japan's internet can download Netflix's entire library in seconds

    Technology
  • Symptoms and causes of rock star's 'aggressive' cancer as his family shares devastating diagnosis
  • Dad who died from aggressive brain tumor suffered little-known symptoms before diagnosis
  • Woman issues warning after routine eye test led to brain tumor diagnosis
  • Woman diagnosed with cancer issues urgent warning after dismissing new contraception as cause of symptoms